Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
157.46
1.66 (1.07%)
At close: Aug 15, 2025, 3:03 PM

Charles River Laboratories International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 28, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 30, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Sep 24, 2022 Jun 25, 2022 Mar 26, 2022 Dec 25, 2021 Sep 25, 2021 Jun 26, 2021 Mar 27, 2021
Revenue
4.03B 4.02B 4.05B 4.06B 4.08B 4.11B 4.13B 4.22B 4.18B 4.09B 3.98B 3.78B 3.69B 3.63B 3.54B 3.43B 3.27B 3.04B
Cost of Revenue
2.05B 2.72B 2.72B 2.65B 2.65B 2.64B 2.63B 2.68B 2.63B 2.63B 2.55B 2.41B 2.35B 2.27B 2.21B 2.14B 2.03B 1.91B
Gross Profit
951M 1.3B 1.33B 1.41B 1.42B 1.47B 1.5B 1.54B 1.55B 1.47B 1.42B 1.37B 1.34B 1.36B 1.33B 1.29B 1.24B 1.13B
Operating Income
124.52M 176.04M 227.35M 527.96M 562.05M 575.35M 617.26M 764.04M 763.51M 787.34M 768.23M 661.34M 666.16M 614.94M 589.86M 545.98M 522.93M 462.15M
Interest Income
5.86M 7.78M 8.57M 8.33M 8.18M 6.59M 5.2M 3.95M 2.7M 1.46M 780K 746K 761K 744K 652K 406K 448K 553K
Pretax Income
-18.15M 30.08M 93.11M 518.61M 540.24M 549.25M 581.28M 617.5M 627.73M 643.18M 622.99M 541.71M 541.87M 525.25M 480.71M 489.5M 501.5M 457.96M
Net Income
-69.22M -31.56M 10.3M 413.08M 431.79M 438.82M 474.62M 474.95M 484.03M 496.33M 486.23M 436.39M 443.35M 422.47M 390.98M 396.6M 396.08M 375.06M
Selling & General & Admin
764.27M 742.51M 751M 752.44M 729.33M 759.3M 747.86M 750.35M 757.96M 687.98M 663.17M 607.64M 572.5M 614.22M 619.92M 618.84M 598.56M 554.77M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
353.89M 386.16M 353.47M 131.27M 133.09M 135.1M 137.44M 138.85M 88.01M 53.73M 56.83M 23.46M 23.86M 29.83M -35.89M 38.62M 76.04M 96.34M
Operating Expenses
1.12B 1.13B 1.1B 883.71M 862.43M 894.4M 885.29M 889.21M 898.12M 793.86M 772.14M 711.37M 673.55M 748.24M 744.78M 741.51M 716.61M 667.61M
Interest Expense
56.44M 119.17M 126.29M 131.6M 135.06M 137.33M 136.71M 137.94M 115.58M 84.24M 59.29M 36.06M 41.14M 53.63M 73.91M 95.51M 97.92M 101.08M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.97B 3.85B 3.82B 3.53B 3.52B 3.54B 3.51B 3.57B 3.53B 3.42B 3.32B 3.12B 3.02B 3.01B 2.95B 2.88B 2.75B 2.58B
Income Tax Expense
46.73M 53.39M 67.82M 90.62M 94.53M 98.36M 100.91M 136.97M 137.62M 141.85M 130.38M 98.38M 91M 95.13M 81.87M 86.3M 100.85M 79.55M
Shares Outstanding (Basic)
49.15M 50.68M 51.14M 51.39M 51.55M 51.44M 51.31M 51.28M 51.22M 51.31M 50.91M 50.87M 50.82M 50.64M 50.47M 50.42M 50.3M 49.98M
Shares Outstanding (Diluted)
49.32M 50.85M 51.14M 51.58M 51.85M 51.84M 51.62M 51.61M 51.47M 51.43M 51.38M 51.28M 51.28M 51.33M 51.55M 51.56M 51.33M 51.08M
EPS (Basic)
-1.32 -0.63 0.29 8.16 8.52 8.66 9.25 9.28 9.48 9.74 9.57 8.62 8.77 8.38 7.77 7.92 7.94 7.54
EPS (Diluted)
-1.33 -0.65 0.26 8.10 8.46 8.61 9.21 9.24 9.43 9.67 9.47 8.49 8.62 8.21 7.60 7.74 7.76 7.38
EBITDA
407.63M 546M 581.14M 990.36M 1.01B 1.01B 1.03B 1.07B 1.07B 1.07B 1.01B 910.44M 897.4M 869.79M 841.17M 839.19M 839.46M 782.82M
EBIT
-3.17M 149.25M 219.4M 650.21M 675.3M 686.59M 717.99M 755.44M 743.31M 727.42M 682.28M 587.52M 592.76M 588.63M 564.37M 585.01M 599.42M 559.04M
Depreciation & Amortization
310.67M 396.75M 361.74M 340.15M 330.82M 322.41M 314.12M 311.15M 306.89M 305.64M 303.87M 294.43M 288.51M 280.19M 266.4M 259.18M 250.07M 239.17M